Showing results for Featured News
-
Hess to step down at dean of IU School of Medicine in 2026
Dean Jay L. Hess, who led the Indiana University School of Medicine to new heights in his decade-long tenure, will leave leadership roles.
Jul 17, 2025 -
Cutting-edge treatment approach addresses neurobehavioral symptoms in neurofibromatosis type 1
A new treatment for neurobehavioral symptoms caused by neurofibromatosis type 1, or NF1, has shown promise.
Jul 16, 2025 -
AI, advanced data metrics forging a new era in cancer research
A new research paper explores how AI, other advanced technologies are being used to diagnose and treat cancer.
Jul 16, 2025 -
New treatment strategy aims to target ‘seed and soil’ of aggressive blood cancer
IU School of Medicine scientists have discovered a potential new strategy to combat leukemia through a special approach that targets both cancer cells and their ...
Jul 15, 2025 -
Researchers bring promising Alzheimer’s drug target closer to potential clinical trials
IU School of Medicine researchers aim to develop a new treatment for neurodegeneration by targeting an immune cell-specific gene associated with Alzheimer's disease.
Jul 14, 2025 -
New digital marker could improve childhood asthma detection
The new detection method is a cheaper and more effective way to predict childhood asthma using readily available data.
Jun 11, 2025 -
IU-led clinical trial aims to use DNA sequencing technology to improve treatment for infections following bone fractures
IU School of Medicine researchers are studying how rapid DNA sequencing technology can help improve treatment for fracture-related infections, a serious health complication that can ...
Jun 09, 2025 -
Innovative breathalyzer device could improve diabetes management using IU technology
For the nearly 40 million Americans living with diabetes, an important part of managing the disease is monitoring blood sugar throughout the day and night. ...
-
Digital screening during primary care visits may lead to earlier dementia detection, care
A trio of studies led by IU School of Medicine researchers found digital testing during primary care visits showed some promise as a tool for early identification of Alzheimer’s disease and dementia in older adults.
Jun 03, 2025 -
IU researcher, AI-powered biotech firm test tumor-shrinking drug for rare disease
Wade Clapp is partnering with Healx to use artificial intelligence to develop novel treatments for shrinking the plexiform neurofibromas found in NF1.